BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
-0.270 (-8.71%)
At close: May 17, 2024, 4:00 PM
+0.060 (2.12%)
After-hours: May 17, 2024, 5:56 PM EDT

BioAtla Market Cap

BioAtla has a market cap or net worth of $136.17 million as of May 17, 2024. Its market cap has decreased by -11.00% in one year.

Market Cap
Enterprise Value
1-Year Change
Stock Price

Market Cap Chart

Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $136.17M, a decrease of -76.43%. That is a compound annual growth rate of -34.47%.


DateMarket Cap% Change
May 17, 2024136.20M-8.71%
May 16, 2024149.20M3.40%
May 15, 2024144.30M14.89%
May 14, 2024125.60M-1.10%
May 13, 2024127.00M-2.53%
May 10, 2024130.30M-6.93%
May 9, 2024140.00M-6.98%
May 8, 2024150.50M1.28%
May 7, 2024148.60M-2.56%
May 6, 2024152.50M-2.43%
May 3, 2024156.30M2.83%
May 2, 2024152.00M-6.23%
May 1, 2024162.10M49.40%
Apr 30, 2024108.50M-12.57%
Apr 29, 2024124.10M1.55%
Apr 26, 2024122.20M12.94%
Apr 25, 2024108.20M-4.25%
Apr 24, 2024113.00M4.92%
Apr 23, 2024107.70M2.67%
Apr 22, 2024104.90M3.66%
Apr 19, 2024101.20M-13.43%
Apr 18, 2024116.90M-3.94%
Apr 17, 2024121.70M-3.64%
Apr 16, 2024126.30M-8.21%
Apr 15, 2024137.60M-8.57%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Seres Therapeutics 139.38M
aTyr Pharma 138.02M
Sangamo Therapeutics 137.79M
DBV Technologies 137.60M
InfuSystem Holdings 137.51M
Renovaro Biosciences 136.53M
Tevogen Bio Holdings 136.25M
Seer, Inc. 135.39M
Market Cap Rankings